BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp
Position in RPRX — Royalty Pharma plc
CIK 1228242
VICTORIA, A1
Position in RPRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,456,603
+$772,970 QoQ
Shares Held
61,648
+10.2% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#227
of 641 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp holds $49,706,140 across 8 Biotechnology names. RPRX ranks #5 (7.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
38,144 | $18,947,269 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
15,583 | $9,716,623 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
19,895 | $5,988,991 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
24,256 | $4,542,663 | |
| 5 | RPRX |
Royalty Pharma plc
This page
|
61,648 | $3,456,603 | |
| 6 | INSM |
INSMED Inc
|
31,414 | $3,349,360 | |
| 7 | INCY |
Incyte Corp
|
25,394 | $2,878,663 | |
| 8 | LEGN |
Legend Biotech Corp
|
28,600 | $825,968 |
All Filings in RPRX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,456,603 | 61,648 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,683,633 | 55,944 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,807,775 | 72,665 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,922,301 | 54,487 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,088,623 | 57,969 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,249,360 | 72,257 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,861,541 | 72,973 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $1,814,775 | 64,149 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,918,733 | 72,762 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,372,997 | 45,209 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,233,319 | 43,906 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $940,509 | 34,654 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,044,268 | 33,971 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,131,918 | 31,416 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,224,132 | 30,975 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,384,040 | 34,446 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,700,097 | 40,440 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,066,594 | 53,044 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,388,848 | 59,946 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,178,922 | 32,621 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,326,272 | 32,356 | Shares | Sole | 2021-09-29 | |
| 2021-03-31 | $1,248,535 | 28,623 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $961,560 | 19,212 | Shares | Sole | 2021-02-02 | |
| No filing history on record for this holder in this stock. | ||||||